Colorectal Cancer Screening: Stool Tests, Colonoscopy, and When to Start

Colorectal cancer screening tests symptom-free adults for early cancer and the polyps that can turn into it, most often using a home stool test on a regular schedule or a colonoscopy roughly every 10 years, starting around age 45 to 50 for people at average risk. What makes this screen unusual is that it can do more than find cancer early: by spotting and removing precursor growths, it can stop some cancers from forming at all.

Colorectal cancer is one of the most common cancers worldwide and a leading cause of cancer death, which is part of why so many countries run organised programmes for it ¹. It is also slow-moving in a useful way. Many cases develop from small growths called polyps over a span of years, and that long runway is exactly what screening is built to exploit.

What colorectal cancer screening is, and is not

Screening is testing people who have no symptoms, to find a cancer or its precursors earlier than they would otherwise appear. It is not the same as a diagnostic test, which is what you have when there is already a symptom to explain, such as rectal bleeding, a persistent change in bowel habit, or unexplained weight loss. If you have symptoms like those, that is a reason to see a clinician promptly, not to wait for your next routine screen.

A positive screen is also not a diagnosis. A stool test that flags hidden blood, for example, has many possible causes, only one of which is cancer. What it tells you is that a closer look is warranted, usually a colonoscopy.

The two main tools: stool tests and colonoscopy

The two dominant approaches are stool-based tests and colonoscopy ¹. Most other methods are variations or additions to these.

Stool-based tests look for blood that is not visible to the eye. The faecal immunochemical test (FIT) is now the more widely used version; the older guaiac faecal occult blood test (FOBT) is the one with the longest trial record. In randomised trials, repeated stool-based screening was shown to reduce deaths from colorectal cancer in the people offered it ². These tests are done at home, involve no preparation, and are simple to repeat, which is why they form the backbone of most national programmes.

Colonoscopy is a direct examination of the bowel lining using a flexible camera, after a bowel-cleansing preparation. Its advantage is that it both finds and treats in one sitting: polyps can be removed during the same procedure, which is the mechanism by which screening can prevent cancer rather than only detect it. The trade-offs are that it is invasive, requires preparation and usually sedation, and carries a small risk of complications such as bleeding or, rarely, perforation.

When to start, and how often

For average-risk adults, organised programmes commonly start around age 45 to 50 and run to roughly age 74, though the exact start age and upper limit differ between countries and guideline bodies ³. Several evidence bodies have moved the recommended start age down toward 45 in response to rising rates in younger adults.

Intervals depend on the test. Stool-based testing is typically done annually or every two years, because each individual test is a snapshot and the schedule is what delivers the benefit ⁴. Colonoscopy is usually repeated about every 10 years when the first examination is normal, reflecting how slowly most polyps progress. If polyps are found and removed, your clinician will often recommend a shorter interval.

Higher risk, and starting earlier

A subset of people are not average risk and are generally advised to start earlier and screen more often. This includes those with a close relative who had colorectal cancer or advanced polyps, a personal history of inflammatory bowel disease such as ulcerative colitis or Crohn’s disease, or an inherited condition such as Lynch syndrome or familial adenomatous polyposis ³. If colorectal cancer runs in your family, that is worth raising specifically, because the right starting age and test may differ from the standard programme.

The benefits and the trade-offs

The benefit is well established: in the recommended age windows, screening reduces deaths from colorectal cancer for the eligible population, and colonoscopy-based approaches can additionally prevent some cancers by removing polyps ⁴. That is a genuinely strong result for a cancer screen.

The trade-offs are real but manageable. Stool tests produce false positives, sending some people to a colonoscopy that turns out clear, and they can miss cancers between scheduled tests. Colonoscopy carries a small procedural risk and depends on good bowel preparation to be accurate. As with any screen, more is not automatically better; the value comes from doing the right test on the right schedule, not from testing constantly. For how this fits into a broader prevention plan, see the cancer screening overview and how to build your own screening plan.

When I first read that a colonoscopy could remove a growth before it ever became cancer, it reframed the whole thing for me. I had been thinking of screening as bad-news detection. For this one cancer, at least, it is closer to maintenance.

This article is general information, not medical advice. Your right start age, test, and interval depend on your personal and family history; discuss them with a qualified clinician.